These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34503219)

  • 61. Inter/intra-observer reproducibility of Gleason scoring in prostate adenocarcinoma in Iranian pathologists.
    Abdollahi A; Meysamie A; Sheikhbahaei S; Ahmadi A; Moradi-Tabriz H; Bakhshandeh M; Hosseinzadeh H
    Urol J; 2012; 9(2):486-90. PubMed ID: 22641492
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Tertiary lymphoid structures: prognostic significance and relationship with tumour-infiltrating lymphocytes in triple-negative breast cancer.
    Lee HJ; Park IA; Song IH; Shin SJ; Kim JY; Yu JH; Gong G
    J Clin Pathol; 2016 May; 69(5):422-30. PubMed ID: 26475777
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Three-dimensional ultrasonography of the breast; An adequate replacement for MRI in neoadjuvant chemotherapy tumour response evaluation? - RESPONDER trial.
    van Egdom LSE; Lagendijk M; Heijkoop EHM; Koning AHJ; van Deurzen CHM; Jager A; van Lankeren W; Koppert LB
    Eur J Radiol; 2018 Jul; 104():94-100. PubMed ID: 29857873
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Joint Region and Nucleus Segmentation for Characterization of Tumor Infiltrating Lymphocytes in Breast Cancer.
    Amgad M; Sarkar A; Srinivas C; Redman R; Ratra S; Bechert CJ; Calhoun BC; Mrazeck K; Kurkure U; Cooper LA; Barnes M
    Proc SPIE Int Soc Opt Eng; 2019 Feb; 10956():. PubMed ID: 31997849
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Importance of choice of materials and methods in PD-L1 and TIL assessment in oropharyngeal squamous cell carcinoma.
    De Meulenaere A; Vermassen T; Creytens D; Aspeslagh S; Deron P; Duprez F; Rottey S; Van Dorpe JA; Ferdinande L
    Histopathology; 2018 Sep; 73(3):500-509. PubMed ID: 29768723
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Peer-to-peer validation of Ki-67 scoring in a pathology quality circle as a tool to assess interobserver variability: are we better than we thought?
    Bernhardt M; Weinhold L; Sanders C; Hommerding O; Lau JF; Toma M; Tischler V; Schmid M; Zienkiewicz T; Hildenbrand R; Gerlach P; Zhou H; Braun M; Müller G; Sieber E; Marko C; Kristiansen G
    APMIS; 2024 Jul; ():. PubMed ID: 38951722
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evaluation of an online training tool for scoring programmed cell death ligand-1 (PD-L1) diagnostic tests for lung cancer.
    Jasani B; Bänfer G; Fish R; Waelput W; Sucaet Y; Barker C; Whiteley JL; Walker J; Hovelinck R; Diezko R
    Diagn Pathol; 2020 Apr; 15(1):37. PubMed ID: 32303234
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study.
    Miyashita M; Sasano H; Tamaki K; Hirakawa H; Takahashi Y; Nakagawa S; Watanabe G; Tada H; Suzuki A; Ohuchi N; Ishida T
    Breast Cancer Res; 2015 Sep; 17(1):124. PubMed ID: 26341640
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Quantitative assessment of the spatial heterogeneity of tumor-infiltrating lymphocytes in breast cancer.
    Mani NL; Schalper KA; Hatzis C; Saglam O; Tavassoli F; Butler M; Chagpar AB; Pusztai L; Rimm DL
    Breast Cancer Res; 2016 Jul; 18(1):78. PubMed ID: 27473061
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The therapeutic candidate for immune checkpoint inhibitors elucidated by the status of tumor-infiltrating lymphocytes (TILs) and programmed death ligand 1 (PD-L1) expression in triple negative breast cancer (TNBC).
    Tomioka N; Azuma M; Ikarashi M; Yamamoto M; Sato M; Watanabe KI; Yamashiro K; Takahashi M
    Breast Cancer; 2018 Jan; 25(1):34-42. PubMed ID: 28488168
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The validity and reliability of an automated method of scoring dental arch relationships in unilateral cleft lip and palate using the modified Huddart-Bodenham scoring system.
    Martin CB; Ma X; McIntyre GT; Wang W; Lin P; Chalmers EV; Mossey PA
    Eur J Orthod; 2016 Aug; 38(4):353-8. PubMed ID: 27105652
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Tumour Stroma Ratio Assessment Using Digital Image Analysis Predicts Survival in Triple Negative and Luminal Breast Cancer.
    Millar EK; Browne LH; Beretov J; Lee K; Lynch J; Swarbrick A; Graham PH
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33322174
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer.
    Leon-Ferre RA; Polley MY; Liu H; Gilbert JA; Cafourek V; Hillman DW; Elkhanany A; Akinhanmi M; Lilyquist J; Thomas A; Negron V; Boughey JC; Liu MC; Ingle JN; Kalari KR; Couch FJ; Visscher DW; Goetz MP
    Breast Cancer Res Treat; 2018 Jan; 167(1):89-99. PubMed ID: 28913760
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Scoring reading parameters: An inter-rater reliability study using the MNREAD chart.
    Baskaran K; Macedo AF; He Y; Hernandez-Moreno L; Queirós T; Mansfield JS; Calabrèse A
    PLoS One; 2019; 14(6):e0216775. PubMed ID: 31173587
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00.
    Pruneri G; Gray KP; Vingiani A; Viale G; Curigliano G; Criscitiello C; Láng I; Ruhstaller T; Gianni L; Goldhirsch A; Kammler R; Price KN; Cancello G; Munzone E; Gelber RD; Regan MM; Colleoni M
    Breast Cancer Res Treat; 2016 Jul; 158(2):323-31. PubMed ID: 27372069
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Histologic classification of tumor-infiltrating lymphocytes in primary cutaneous malignant melanoma. A study of interobserver agreement.
    Busam KJ; Antonescu CR; Marghoob AA; Nehal KS; Sachs DL; Shia J; Berwick M
    Am J Clin Pathol; 2001 Jun; 115(6):856-60. PubMed ID: 11392882
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Inter-observer and intra-observer agreement between embryologists during selection of a single Day 5 embryo for transfer: a multicenter study.
    Storr A; Venetis CA; Cooke S; Kilani S; Ledger W
    Hum Reprod; 2017 Feb; 32(2):307-314. PubMed ID: 28031323
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Correlation between
    Murakami W; Tozaki M; Sasaki M; Hida AI; Ohi Y; Kubota K; Sagara Y
    Eur J Radiol; 2020 Feb; 123():108773. PubMed ID: 31918248
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Evaluation of tumor-infiltrating lymphocytes using routine H&E slides predicts patient survival in resected non-small cell lung cancer.
    Rakaee M; Kilvaer TK; Dalen SM; Richardsen E; Paulsen EE; Hald SM; Al-Saad S; Andersen S; Donnem T; Bremnes RM; Busund LT
    Hum Pathol; 2018 Sep; 79():188-198. PubMed ID: 29885403
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.
    Dieci MV; Radosevic-Robin N; Fineberg S; van den Eynden G; Ternes N; Penault-Llorca F; Pruneri G; D'Alfonso TM; Demaria S; Castaneda C; Sanchez J; Badve S; Michiels S; Bossuyt V; Rojo F; Singh B; Nielsen T; Viale G; Kim SR; Hewitt S; Wienert S; Loibl S; Rimm D; Symmans F; Denkert C; Adams S; Loi S; Salgado R;
    Semin Cancer Biol; 2018 Oct; 52(Pt 2):16-25. PubMed ID: 29024776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.